Horizon Pharma also formally commits to become a Pledge 1% company
“It is a great honor to be recognized by PEOPLE and Great Place to Work® as one of the ‘50 Companies That Care,’” said Timothy P. Walbert, chairman, president and chief executive officer, Horizon Pharma plc. “This distinction is a realization of what we work so hard for at Horizon – to be a positive force for good amid a constantly changing health care system. Our social responsibility programs, patient advocacy support and awareness, dedication to individual employee volunteerism, as well as inclusion initiatives, reflect our company ideals, a commitment to our patients and the communities we serve.”
PEOPLE partnered with Great Place to Work®, a global people analytics and consulting firm, to analyze employees’ survey feedback on how their workplaces make a difference in their lives and communities, and to consider the generosity of each organization’s benefits, as well as their philanthropic and community support.
In furthering the company’s dedication to service, Horizon has also joined Pledge 1%, a corporate philanthropy movement that empowers companies to donate 1% of product, 1% of equity, 1% of profit or 1% of employee time to improve communities around the world. Joined by more than 5,500 organizations across 100 countries from all different sectors, Horizon is one of the first biopharmaceutical companies to make this important commitment.
Horizon supports four pillars of giving – children’s healthcare, innovation, STEAM (science, technology, engineering, arts and math) and its therapeutic areas. Through these platforms, the company has been able to donate $9 million in community impact and support.
About “50 Companies That Care”
To identify the “50 Companies That Care,” PEOPLE teamed up with Great Place to Work to produce the list using the research and consulting firm’s extensive database and inside knowledge of outstanding workplaces around the globe. PEOPLE magazine partnered with Great Place to Work® to produce the ranking using the research firm’s extensive database and inside knowledge of outstanding workplaces around the globe. Rankings are based on surveys representing over 4.5 million employee’s experiences of how their workplaces have made a difference in their lives and in their communities. Rankings also reflect Great Place to Work’s assessment of the generosity of each organization’s benefits, philanthropic and community support, with particular focus on activities occurring in the last year.
About Pledge 1%
Pledge 1% is an effort spearheaded by Atlassian, Rally, Salesforce and Tides to accelerate their shared vision around integrating philanthropy into businesses around the world. Pledge 1% encourages and challenges individuals and companies to pledge 1% of equity, profit, product and/or employee time for their communities, because pledging a small portion of future success can have a huge impact on tomorrow. Pledge 1% offers companies turnkey tools and best practices, making it accessible for any company to incorporate philanthropy into their business model. To learn more or to take the pledge, please visit www.pledge1percent.org.
About Horizon Pharma plc
Horizon Pharma plc is focused on researching, developing and commercializing innovative medicines that address unmet treatment needs for rare and rheumatic diseases. By fostering a growing pipeline of medicines in development and exploring all potential uses for currently marketed medicines, we strive to make a powerful difference for patients, their caregivers and physicians. For us, it’s personal: by living up to our own potential, we are helping others live up to theirs. For more information, please visit www.horizonpharma.com, follow us @HZNPplc on Twitter or like us on Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180725005403/en/
Contacts
U.S. Media Contact:
Geoffrey Curtis
Senior Vice President, Corporate Affairs and Chief Communications Officer
media@horizonpharma.com
or
Ireland Media Contact:
Ray Gordon
Gordon MRM
ray@gordonmrm.ie
Source: Horizon Pharma plc